VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ESTAEstablishment Labs Holdings Inc.
$84.81$2.5B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

ESTA logoEstablishment Labs Holdings Inc.(ESTA)Earnings, Financials & Key Ratios

ESTA•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryAesthetics, dermatology, and wound care
AboutEstablishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.Show more
  • Revenue$211M+27.1%
  • EBITDA-$33M+22.7%
  • Net Income-$51M+39.6%
  • EPS (Diluted)-1.72+42.7%
  • Gross Margin69.32%+5.1%
  • EBITDA Margin-15.52%+39.2%
  • Operating Margin-18.48%+38.6%
  • Net Margin-24.19%+52.5%
  • ROE-133.25%+43.7%

ESTA Key Insights

Establishment Labs Holdings Inc. (ESTA) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 89 (top 11%)
  • ✓Strong 5Y sales CAGR of 20.0%
  • ✓Trading near 52-week high

✗Weaknesses

  • ✗High debt to equity ratio of 11.2x
  • ✗Negative free cash flow
  • ✗Expensive at 106.7x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when ESTA posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ESTA Price & Volume

Establishment Labs Holdings Inc. (ESTA) stock price & volume — 10-year historical chart

Loading chart...

ESTA Growth Metrics

Establishment Labs Holdings Inc. (ESTA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years20.04%
3 Years9.29%
TTM34.86%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM50.92%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM52.47%

Return on Capital

10 Years-48.25%
5 Years-23.57%
3 Years-22.8%
Last Year-14.09%

ESTA Recent Earnings

Establishment Labs Holdings Inc. (ESTA) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 6, 2026
Metric
Actual
Est
EPS
$0.40-12.7%
$0.35
Rev
$60M+4.3%
$57M
Q1 2026
Feb 24, 2026
Metric
Actual
Est
EPS
$0.09+58.1%
$0.21
Rev
$65M+1.3%
$64M
Q4 2025
Nov 5, 2025
Metric
Actual
Est
EPS
$0.38+29.6%
$0.54
Rev
$54M-15.7%
$64M
Q3 2025
Aug 7, 2025
Metric
Actual
Est
EPS
$0.57-5.6%
$0.54
Rev
$51M-2.2%
$52M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 6, 2026
$0.40vs $0.35-12.7%
$60Mvs $57M+4.3%
Q1 2026Feb 24, 2026
$0.09vs $0.21+58.1%
$65Mvs $64M+1.3%
Q4 2025Nov 5, 2025
$0.38vs $0.54+29.6%
$54Mvs $64M-15.7%
Q3 2025Aug 7, 2025
$0.57vs $0.54-5.6%
$51Mvs $52M-2.2%
Based on last 12 quarters of dataView full earnings history →

ESTA Peer Comparison

Establishment Labs Holdings Inc. (ESTA) competitors in Aesthetics, dermatology, and wound care — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
ALGN logoALGNAlign Technology, Inc.Direct Competitor13.04B182.0832.230.9%10.5%10.7%0.03
INMD logoINMDInMode Ltd.Direct Competitor849.01M13.409.37-6.16%23.27%13.28%0.02
AEYE logoAEYEAudioEye, Inc.Direct Competitor78.83M6.31-25.2414.52%-9.05%-70.95%2.75
ATEC logoATECAlphatec Holdings, Inc.Product Competitor1.33B8.81-9.1824.95%-21.07%-443.09%17.21
NVCR logoNVCRNovoCure LimitedProduct Competitor1.62B14.28-11.708.28%-25.66%-50.82%0.85
XTNT logoXTNTXtant Medical Holdings, Inc.Product Competitor61.8M0.4414.6914.21%1.5%3.68%0.56
SYK logoSYKStryker CorporationSupply Chain117.88B307.8036.6411.16%12.92%15.04%0.66
ZBH logoZBHZimmer Biomet Holdings, Inc.Supply Chain17.22B87.9724.787.2%9.05%5.77%0.59

Compare ESTA vs Peers

Establishment Labs Holdings Inc. (ESTA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ALGN

Most directly comparable listed peer for ESTA.

Scale Benchmark

vs ABT

Larger-name benchmark to compare ESTA against a more recognizable public peer.

Peer Set

Compare Top 5

vs ALGN, INMD, AEYE, ATEC

ESTA Income Statement

Establishment Labs Holdings Inc. (ESTA) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
34.68M61.21M89.56M84.68M126.68M161.7M165.15M166.03M211.08M229.58M
Revenue Growth %
75.15%76.49%46.33%-5.46%49.61%27.64%2.13%0.53%27.14%34.86%
Cost of Goods Sold
16.98M25.09M34.7M32.17M41.28M55.1M58.17M56.5M64.77M68.74M
COGS % of Revenue
48.96%40.99%38.75%38%32.58%34.08%35.22%34.03%30.68%-
Gross Profit
17.7M▲ 0%
36.12M▲ 104.0%
54.86M▲ 51.9%
52.5M▼ 4.3%
85.4M▲ 62.7%
106.59M▲ 24.8%
106.98M▲ 0.4%
109.53M▲ 2.4%
146.31M▲ 33.6%
160.84M▲ 0%
Gross Margin %
51.04%59.01%61.25%62%67.42%65.92%64.78%65.97%69.32%70.06%
Gross Profit Growth %
75.34%104.03%51.89%-4.3%62.67%24.81%0.36%2.38%33.58%-
Operating Expenses
37.69M59.98M85.8M80.42M110.54M146.25M172M159.51M185.32M189.41M
OpEx % of Revenue
108.66%98%95.8%94.97%87.26%90.45%104.15%96.08%87.8%-
Selling, General & Admin
30.82M47.3M70.81M66.63M92.23M125.98M145.57M139.81M165.07M168.97M
SG&A % of Revenue
88.87%77.27%79.06%78.68%72.8%77.91%88.15%84.21%78.2%-
Research & Development
6.86M12.69M14.99M13.79M18.32M20.27M26.43M19.71M20.25M20.43M
R&D % of Revenue
19.79%20.73%16.74%16.29%14.46%12.53%16%11.87%9.59%-
Other Operating Expenses
0000000000
Operating Income
-19.98M▲ 0%
-23.86M▼ 19.4%
-30.94M▼ 29.7%
-27.92M▲ 9.8%
-25.14M▲ 9.9%
-39.66M▼ 57.7%
-65.03M▼ 64.0%
-49.99M▲ 23.1%
-39.01M▲ 22.0%
-28.57M▲ 0%
Operating Margin %
-57.62%-38.99%-34.55%-32.97%-19.84%-24.53%-39.37%-30.11%-18.48%-12.45%
Operating Income Growth %
-26.21%-19.42%-29.66%9.78%9.94%-57.75%-63.97%23.13%21.96%-
EBITDA
-18.04M-21.06M-27.64M-24.25M-21.03M-35.49M-60.14M-42.41M-32.77M-24.33M
EBITDA Margin %
-52.03%-34.41%-30.86%-28.64%-16.6%-21.95%-36.42%-25.54%-15.52%-10.6%
EBITDA Growth %
-18.39%-16.74%-31.22%12.26%13.27%-68.72%-69.47%29.48%22.74%50.72%
D&A (Non-Cash Add-back)
1.94M2.8M3.3M3.66M4.11M4.17M4.88M7.58M04.98M
EBIT
-24.37M-12.07M-28.81M-28.64M-30.65M-61.06M-63.19M-63.8M-32.77M-25.33M
Net Interest Income
-10.4M-8.8M-8.69M-9.36M-9.04M-11.67M-14.37M-19.35M-24.83M-26.29M
Interest Income
19K16K4K15K23K87K1.02M1.48M423K199K
Interest Expense
10.42M8.81M8.7M9.37M9.06M11.76M15.39M20.83M25.26M26.49M
Other Income/Expense
-14.81M2.98M-6.57M-10.1M-14.57M-33.17M-13.56M-34.64M-19.01M-22.75M
Pretax Income
-34.79M▲ 0%
-20.88M▲ 40.0%
-37.51M▼ 79.6%
-38.02M▼ 1.4%
-39.71M▼ 4.5%
-72.82M▼ 83.4%
-78.58M▼ 7.9%
-84.63M▼ 7.7%
-58.02M▲ 31.4%
-51.32M▲ 0%
Pretax Margin %
-100.32%-34.12%-41.88%-44.9%-31.35%-45.04%-47.58%-50.97%-27.49%-22.35%
Income Tax
105K215K640K104K1.43M2.38M-81K-32K-6.96M-7.58M
Effective Tax Rate %
-0.3%-1.03%-1.71%-0.27%-3.59%-3.28%0.1%0.04%11.99%14.78%
Net Income
-34.9M▲ 0%
-21.1M▲ 39.5%
-38.15M▼ 80.8%
-38.12M▲ 0.1%
-41.14M▼ 7.9%
-75.21M▼ 82.8%
-78.5M▼ 4.4%
-84.6M▼ 7.8%
-51.06M▲ 39.6%
-43.74M▲ 0%
Net Margin %
-100.62%-34.47%-42.59%-45.02%-32.47%-46.51%-47.53%-50.95%-24.19%-19.05%
Net Income Growth %
-57.48%39.54%-80.82%0.08%-7.92%-82.82%-4.38%-7.76%39.64%50.92%
Net Income (Continuing)
-34.9M-21.1M-38.15M-38.12M-41.14M-75.21M-78.5M-84.6M-51.06M-43.74M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
-1.89▲ 0%
-1.22▲ 35.4%
-1.86▼ 52.5%
-1.63▲ 12.4%
-1.72▼ 5.5%
-3.08▼ 79.1%
-3.07▲ 0.3%
-3.00▲ 2.3%
-1.72▲ 42.7%
-1.48▲ 0%
EPS Growth %
-57.5%35.45%-52.46%12.37%-5.52%-79.07%0.32%2.28%42.67%52.47%
EPS (Basic)
-2.33-1.22-1.86-1.63-1.72-3.08-3.07-3.00-1.72-
Diluted Shares Outstanding
18.49M17.35M20.54M23.32M23.97M24.46M25.6M28.16M29.62M29.62M
Basic Shares Outstanding
14.98M17.35M20.54M23.32M23.97M24.46M25.6M28.16M29.62M29.62M
Dividend Payout Ratio
----------

ESTA Balance Sheet

Establishment Labs Holdings Inc. (ESTA) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
39.38M99.44M95.84M132.3M113.27M149.9M174.9M243.04M249.94M245.83M
Cash & Short-Term Investments
10.86M52.64M37.66M84.52M53.41M66.36M40.03M90.35M75.57M68.1M
Cash Only
10.86M52.64M37.66M84.52M53.41M66.36M40.03M90.35M75.57M68.1M
Short-Term Investments
0000000000
Accounts Receivable
13.11M17.65M22.77M19.13M24.44M35.42M46.92M65M77.5M77.08M
Days Sales Outstanding
137.96105.2492.7882.4570.4179.96103.69142.9134.01117.69
Inventory
13.17M24.84M28.66M23.21M28.41M36.58M79.47M78.77M85.61M86.66M
Days Inventory Outstanding
283.18361.44301.43263.31251.19242.32498.62508.84482.46471.39
Other Current Assets
04.3M1.27M2.09M1.77M1.57M2.42M2.61M11.26M13.99M
Total Non-Current Assets
17.71M17.14M20.69M24.09M26.26M61.16M93.74M103.79M107.23M105.21M
Property, Plant & Equipment
13.5M12.91M16.42M18.81M20.86M54.79M80.59M83.59M79.95M78.58M
Fixed Asset Turnover
2.57x4.74x5.46x4.50x6.07x2.95x2.05x1.99x2.64x2.87x
Goodwill
465K465K465K465K465K465K465K1.21M1.21M1.21M
Intangible Assets
3.4M3.44M3.44M4.15M4.37M4.61M7.99M11.68M9.94M9.3M
Long-Term Investments
75K000000000
Other Non-Current Assets
347K315K368K664K558K1.29M4.7M7.31M16.12M16.11M
Total Assets
57.09M▲ 0%
116.57M▲ 104.2%
116.53M▼ 0.0%
156.39M▲ 34.2%
139.53M▼ 10.8%
211.06M▲ 51.3%
268.64M▲ 27.3%
346.83M▲ 29.1%
357.17M▲ 3.0%
351.04M▲ 0%
Asset Turnover
0.61x0.53x0.77x0.54x0.91x0.77x0.61x0.48x0.59x0.67x
Asset Growth %
93.14%104.17%-0.04%34.2%-10.78%51.27%27.28%29.11%2.98%43.8%
Total Current Liabilities
57.44M16.45M23.24M25.9M31.89M38.96M57.15M68.28M82.14M83.15M
Accounts Payable
9.13M6.24M10.37M9.72M14.47M20.03M41.62M44.76M43.11M41.81M
Days Payables Outstanding
196.2990.76109.02110.29127.99132.7261.16289.16242.94239.53
Short-Term Debt
24.09M000000012.41M0
Deferred Revenue (Current)
2.33M908K785K1.21M769K1.69M1.84M1.75M03.24M
Other Current Liabilities
21.89M4.12M7.53M8.63M9.08M9.88M4.57M5.53M24.91M41.34M
Current Ratio
0.69x6.05x4.12x5.11x3.55x3.85x3.06x3.56x3.04x2.96x
Quick Ratio
0.46x4.54x2.89x4.21x2.66x2.91x1.67x2.41x2.00x1.91x
Cash Conversion Cycle
224.85375.91285.19235.46193.6189.58341.16362.59373.53349.55
Total Non-Current Liabilities
4.67M30.64M53.67M55.53M56.9M180.29M193.1M225.46M251.48M253.1M
Long-Term Debt
022.32M48.14M49.83M51.91M175.46M188.74M219.58M247.52M2.41M
Capital Lease Obligations
599K001.92M1.9M3.2M2.71M4.2M2.82M11.57M
Deferred Tax Liabilities
03.58M00000000
Other Non-Current Liabilities
4.07M7.13M4.19M1.91M703K-44K147K554K0250.69M
Total Liabilities
62.11M47.09M76.92M81.43M88.79M219.25M250.25M293.74M333.62M336.25M
Total Debt
24.09M22.32M48.4M52.54M54.21M179.35M192.22M225.29M264.47M2.41M
Net Debt
13.22M-30.32M10.74M-31.98M793K112.99M152.19M134.95M188.9M-65.69M
Debt / Equity
-0.32x1.22x0.70x1.07x-10.45x4.24x11.23x0.16x
Debt / EBITDA
----------0.10x
Net Debt / EBITDA
---------2.70x
Interest Coverage
-2.34x-1.37x-3.31x-3.06x-3.38x-5.19x-4.11x-3.06x-1.30x-0.96x
Total Equity
-5.01M▲ 0%
69.48M▲ 1486.1%
39.61M▼ 43.0%
74.96M▲ 89.2%
50.74M▼ 32.3%
-8.19M▼ 116.1%
18.39M▲ 324.7%
53.09M▲ 188.6%
23.55M▼ 55.7%
14.78M▲ 0%
Equity Growth %
81.04%1486.1%-42.99%89.23%-32.31%-116.13%324.74%188.64%-55.65%-216.72%
Book Value per Share
-0.274.001.933.212.12-0.330.721.890.790.50
Total Shareholders' Equity
-5.01M69.48M39.61M74.96M50.74M-8.19M18.39M53.09M23.55M14.78M
Common Stock
41.27M145.71M147.69M213.47M219.74M223.64M315.63M420.36M433.38M434.53M
Retained Earnings
-67.88M-88.97M-127.13M-165.25M-206.38M-281.59M-360.1M-444.69M-495.76M-509.14M
Treasury Stock
-6.46M-2.85M-2.85M-2.85M-2.85M-2.85M-2.85M-2.85M-2.85M0
Accumulated OCI
76K449K691K2.87M3.66M2.71M1.96M3.29M1.16M2.37M
Minority Interest
0000000000

ESTA Cash Flow Statement

Establishment Labs Holdings Inc. (ESTA) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-31.97M-33.88M-29.98M-12.51M-27.53M-52.17M-88.51M-58.52M-50.89M-34.81M
Operating CF Margin %
-92.18%-55.36%-33.48%-14.77%-21.73%-32.26%-53.6%-35.25%-24.11%-
Operating CF Growth %
-124.1%-5.99%11.52%58.28%-120.08%-89.47%-69.68%33.89%13.03%154.41%
Net Income
-34.9M-21.1M-38.15M-38.12M-41.14M-75.21M-78.5M-84.6M-51.06M-43.74M
Depreciation & Amortization
1.94M2.81M3.29M3.71M4.12M4.34M4.88M7.58M-9.56M5.34M
Stock-Based Compensation
3.3M7.32M6.53M5.72M10.41M13.36M14.86M15.37M-11.41M3.09M
Deferred Taxes
4.96M-13.94M02.48M7K86K-3.71M-2.18M6.96M9.3M
Other Non-Cash Items
7.05M5.04M2.95M1.39M5.51M26.8M8.08M20.81M27.36M-747.95K
Working Capital Changes
-14.32M-14.02M-4.6M12.31M-6.44M-21.54M-34.13M-15.5M-13.17M-8.07M
Change in Receivables
-6.91M-4.67M-5.51M3.81M-6.7M-12.33M-11.56M-26.28M-11.47M-12.03M
Change in Inventory
-6.44M-6.98M-3.37M4.79M-7.64M-10.9M-42.23M-471K-7.06M2.47M
Change in Payables
-878K-3.9M1.83M-910K4.96M4.38M18.96M6.67M-2.3M-6.26M
Cash from Investing
-845K-5.73M-7.77M-5.56M-7.16M-34.79M-24.55M-15.61M-7.03M-7.7M
Capital Expenditures
-941K-1.77M-6.29M-3.91M-6.73M-34.27M-7.91M-6.11M0-7.48M
CapEx % of Revenue
2.71%2.9%7.02%4.61%5.31%21.19%4.79%3.68%2.87%3.26%
Acquisitions
0000000-50K-4.37M-3.75M
Investments
----------
Other Investing
96K-3.96M-1.48M-1.65M-434K-525K-16.64M-9.45M-2.66M3.53M
Cash from Financing
42.99M81.53M22.79M64.67M4.05M100.25M86.23M125.89M40.43M40.08M
Debt Issued (Net)
22.97M-311K24.51M-277K-175K96.39M024.47M33.48M33.73M
Equity Issued (Net)
-4.51M0063.85M4.58M3.87M84.54M99.48M7.59M7.54M
Dividends Paid
0000000000
Share Repurchases
-4.51M000000000
Other Financing
24.53M81.84M-1.72M1.09M-356K-4K1.69M1.94M-637K-1.19M
Net Change in Cash
10.38M▲ 0%
41.77M▲ 302.3%
-14.98M▼ 135.9%
46.87M▲ 412.8%
-31.11M▼ 166.4%
12.94M▲ 141.6%
-26.32M▼ 303.4%
50.31M▲ 291.2%
-14.78M▼ 129.4%
-1.08M▲ 0%
Free Cash Flow
-32.91M▲ 0%
-35.66M▼ 8.3%
-36.98M▼ 3.7%
-16.42M▲ 55.6%
-34.26M▼ 108.7%
-86.43M▼ 152.3%
-113.06M▼ 30.8%
-74.08M▲ 34.5%
-56.94M▲ 23.1%
-42.12M▲ 0%
FCF Margin %
-94.9%-58.26%-41.29%-19.39%-27.04%-53.45%-68.46%-44.62%-26.98%-18.35%
FCF Growth %
-32.6%-8.34%-3.72%55.61%-108.69%-152.28%-30.81%34.48%23.14%45.05%
FCF per Share
-1.78-2.06-1.80-0.70-1.43-3.53-4.42-2.63-1.92-1.42
FCF Conversion (FCF/Net Income)
0.92x1.61x0.79x0.33x0.67x0.69x1.13x0.69x1.00x0.96x
Interest Paid
2.86M5.38M5.95M6.96M6.93M5.36M5.69M9.81M05.14M
Taxes Paid
147K136K649K316K652K2.13M2.17M1.74M0154K

ESTA Key Ratios

Establishment Labs Holdings Inc. (ESTA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
--65.45%-69.94%-66.54%-65.46%-353.48%-1537.75%-236.67%-133.25%-225.86%
Return on Invested Capital (ROIC)
-154.14%-75.55%-51.84%-44.86%-39.9%-38.05%-35.42%-20.91%-14.61%-15.1%
Gross Margin
51.04%59.01%61.25%62%67.42%65.92%64.78%65.97%69.32%70.06%
Net Margin
-100.62%-34.47%-42.59%-45.02%-32.47%-46.51%-47.53%-50.95%-24.19%-19.05%
Debt / Equity
-0.32x1.22x0.70x1.07x-10.45x4.24x11.23x0.16x
Interest Coverage
-2.34x-1.37x-3.31x-3.06x-3.38x-5.19x-4.11x-3.06x-1.30x-0.96x
FCF Conversion
0.92x1.61x0.79x0.33x0.67x0.69x1.13x0.69x1.00x0.96x
Revenue Growth
75.15%76.49%46.33%-5.46%49.61%27.64%2.13%0.53%27.14%34.86%
Related:ESTA Dividend History·ESTA Revenue History·ESTA Price History·ESTA P/E History·ESTA Financial Ratios·ESTA Institutional Holders

ESTA SEC Filings & Documents

Establishment Labs Holdings Inc. (ESTA) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 6, 2026·SEC

Material company update

Apr 30, 2026·SEC

Material company update

Feb 24, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 27, 2026·SEC

FY 2025

Feb 28, 2025·SEC

FY 2024

Mar 4, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 8, 2026·SEC

FY 2025

Nov 7, 2025·SEC

FY 2025

Aug 7, 2025·SEC

ESTA Frequently Asked Questions

Establishment Labs Holdings Inc. (ESTA) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Establishment Labs Holdings Inc. (ESTA) reported $229.6M in revenue for fiscal year 2025. This represents a 1059% increase from $19.8M in 2016.

Establishment Labs Holdings Inc. (ESTA) grew revenue by 27.1% over the past year. This is strong growth.

Establishment Labs Holdings Inc. (ESTA) reported a net loss of $43.7M for fiscal year 2025.

Dividend & Returns

Establishment Labs Holdings Inc. (ESTA) has a return on equity (ROE) of -133.3%. Negative ROE indicates the company is unprofitable.

Establishment Labs Holdings Inc. (ESTA) had negative free cash flow of $42.1M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in ESTA back in 2016?

Total return calculator · dividends reinvested · 10+ years of data

See returns →

How much would $100/month in ESTA be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →